510(k) K202862
K202862 is an FDA 510(k) premarket notification submitted by Vitrolife Sweden AB for the device "Gx-IVF, Gx-TL, Gx-MOPS PLUS". The FDA issued a decision of Substantially Equivalent on May 14, 2021. The device falls under product code MQL (Media, Reproductive), a Class II device regulated under 21 CFR 884.6180. Vitrolife Sweden AB has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 14, 2021
- Date Received
- September 28, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Media, Reproductive
- Device Class
- Class II
- Regulation Number
- 884.6180
- Review Panel
- OB
- Submission Type